According to a study published in Frontiers of Medicine, early-onset intrahepatic cholestasis of pregnancy (ICP) is associated with a greater risk of gestational diabetes mellitus (GDM). For this retrospective cohort study, the investigators analyzed data from 752 pregnancies from January 2015 to December 2023. Early-onset ICP was defined as diagnosis before the 24th week of gestation, and 122 participants had early-onset ICP. ...
Advertisement
Disparities in diabetes care in the US vary by state.
Nearly half (49%) of LGBTQ+ young people aged 13-17 in the U.S. have experienced bullying in the last year
Omalizumab treatment in CSU patients leads to significant changes in T-cell subpopulations.
Patients with both asthma and chronic urticaria have more severe allergic responses.
Omalizumab effectively reduces symptoms in CSU patients, but a 300 mg dose is recommended.
A systematic review found that biologic omalizumab is cost-effective for treating H1 antihistamine–refractory CSU.
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
Urban Health Weekly
Dr. Craig Eagle talks about Shield blood-based Colorectal Cancer Test.
Dr. Damien Croft on addressing medical bias for improved women’s health outcomes.
Henry McMillan on engagement of Dermatologists, Allergists, and Advanced Practice Providers in new treatment trends training.
Quintin Maidment talks about the Clinical Trial Enrollment Process
